July 17, 2017

New OIG Report Confirms Our Worst Fears About 340B Contract Pharmacy Abuses

Drug Channels posted an article titled, “New OIG Report Confirms Our Worst Fears About 340B Contract Pharmacy Abuses.” The article reads in part as follows;

“Moments after yesterday’s post on the booming 340B contract pharmacy market, the Office of Inspector General (OIG) released the first of its three planned reports on the 340B drug discount program: Contract Pharmacy Arrangements in the 340B Program.

OIG’s research confirms many long-suspected problems regarding oversight, diversion, and the mystery methodologies for identifying 340B-eligible prescriptions.

But here’s what’s most troubling: the neediest patients are not benefiting from 340B discounts. In OIG’s sample, two-thirds of the hospitals do not offer the 340B price to uninsured patients. Wow.

These 340B contract pharmacy shenanigans need to stop. Based on the OIG report, uninsured and indigent patients aren’t benefiting from 340B drug discounts. Hospitals should stop hiding behind vague language about “stretching scare federal resources” and come clean about who really gains from 340B contract pharmacies.

Read on for highlights from this depressing report on the out-of-control 340B program.”

Click here to read the article further.

No Comments »

No comments yet.

Leave a Reply

Your email address will not be published.